Welcome
Support Centre
21 November 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Effectiveness of Bupivacaine in Pain Management following Breast Augmentation
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN81120207
Date ISRCTN assigned28/09/2007
Local reference number(s)N0072186040
Public titleEffectiveness of Bupivacaine in Pain Management following Breast Augmentation
Scientific title
AcronymN/A
Disease/condition/study domainSigns and Symptoms: Pain
Study hypothesis1. Is bupivacaine better than placebo in reducing the post-operative pain?
2. Does bupivacaine used as supplement reduce the opiate dosage?
Design/methodologyRandomised double blind controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Patients undergoing breast augmentation
2. For correction of congenital anomaly or asymmetry. This group is usually young population, so usually not associated with co-morbid conditions which might complicate result.
Participants - exclusion criteria1. Patients undergoing augmentation following mastectomy or as part of other reconstruction
2. Patients with multiple co-morbidity
Patient information material
Anticipated start date01/08/2006
Anticipated end date01/08/2009
Status of trialOngoing
Target number of participantsTotal 50; 25 in each group.
InterventionsA blinded member of the team will assess the pain at 2,4 and hours after the operation. Length of hospital stay is also recorded.
The data analysis will take place at Countess of Chester Hospital (COCH). The research team at COCH will analyse the data using SPSS software.
Primary outcome measure(s)Is bupivacaine superior than placebo in pain control following breast augmentation?
Secondary outcome measure(s)1. Does bupivacaine reduce opiate requirement?
2. Does it reduce hospital stay?
3. Does it reduce the incidence of opiate related adverse effects?
Sources of fundingCountess of Chester NHS Foundation Trust
NHS R&D Support Funding
Sponsor nameRecord Provided by the NHSTCT Register - 2007 Update - Department of Health
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor fax+44
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameMr S Jayagopal
Contact detailsCountess of Chester Hospital NHS Foundation Trust
Liverpool Road


Chester
United Kingdom
CH2 1UL
Contact telephone+44 01244 365000
Contact fax+44 01244 366277
Contact emailsathish_jayagopal@yahoo@co.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN81120207
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central